Ismael et al.26 reported a significant improvement in neurological function and reduced cerebral edema following administration of an NLRP3 inhibitor (i.e., MCC950) at 1 and 3 h post-TBI in a controlled cortical impact mouse model. The gene discussed is NLRP3; the disease is brain edema.